2025-525025-12-00暂停1 期
A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people
适应症
试验速览
- 阶段
- 1 期
- 状态
- 暂停
- 入组人数
- 18
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Lars Lykke Thomsen
Scientific
Pharmacosmos A/S
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A study to compare how the body absorbs different formulations of a new medicine, and how food affects drug absorption, in healthy participants2025-523430-14-00Janssen Cilag International18
进行中（未招募）
1 期
A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain TumoursNCT07441707Ipsen6
招募中
1 期
A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaNCT07295951Janssen Research & Development, LLC10
已完成
1 期
A two-part trial in healthy volunteers to find out how long JNJ-77242113 stays in and acts on the body when administered as different tablet formulations and under different food and water conditions, and to assess the acceptability profile (taste, palatability, and smell) of JNJ-77242113 formulations.2024-512220-11-00Janssen Cilag International76
已完成
1 期
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal2023-503528-25-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG36